ProBase Pharma Overview
- Founded
- 2012
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
ProBase Pharma General Information
Description
Provider of laboratory contract services intended to offer molecular-based rapid testing services. The company's services offers molecular biological testing methods on pharmaceutical raw materials, process intermediates, and finished products, enabling clients to identify bacteria using molecular methods such as PCR, DNA sequencing, and mass spectrometry.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Parent Company
BaseClear
Primary Office
- Sylviusweg 74
- 2333 BE Leiden
- Netherlands
+31 071 000 0000
ProBase Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 13-Jan-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC | Completed | Generating Revenue | ||||
| 1. Joint Venture | 01-Jan-2012 | Completed | Generating Revenue |
ProBase Pharma Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Jonghoud International | Family Office | Minority | 000 0000 | 000000 0 | |
| Sinensis Life Sciences | Corporation | Majority | 000 0000 | 000000 0 |